This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2020 Oct 1;41(37):3530-3532.

doi: 10.1093/eurheartj/ehaa436.

Beta-blockers after acute myocardial infarction: an old drug in urgent need of new evidence!

Rafael Harari¹, Sripal Bangalore¹

Affiliations

PMID: 32734292
DOI: 10.1093/eurheartj/ehaa436

Editorial

Beta-blockers after acute myocardial infarction: an old drug in urgent need of new evidence!

Rafael Harari et al. Eur Heart J. 2020.

. 2020 Oct 1;41(37):3530-3532.

doi: 10.1093/eurheartj/ehaa436.

Authors

Rafael Harari¹, Sripal Bangalore¹

Affiliation

¹ Leon H. Charney Division of Cardiology, Department of Medicine, New York University Grossman School of Medicine, New York, USA.

PMID: 32734292
DOI: 10.1093/eurheartj/ehaa436

No abstract available

PubMed Disclaimer

Comment on

Long-term β-blocker therapy and clinical outcomes after acute myocardial infarction in patients without heart failure: nationwide cohort study.
Kim J, Kang D, Park H, Kang M, Park TK, Lee JM, Yang JH, Song YB, Choi JH, Choi SH, Gwon HC, Guallar E, Cho J, Hahn JY. Kim J, et al. Eur Heart J. 2020 Oct 1;41(37):3521-3529. doi: 10.1093/eurheartj/ehaa376. Eur Heart J. 2020. PMID: 32542362

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems